Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. - Wikidata - wikimedia - TriplyDB

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.

http://www.wikidata.org/entity/Q34058099

about

Emerging Threats in Antifungal-Resistant Fungal Pathogens Tipping the balance both ways: drug resistance and virulence in Candida glabrata Clinical perspectives on echinocandin resistance among Candida species T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis Echinocandin resistance: an emerging clinical problem?Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study.Drug-resistant Candida glabrata infection in cancer patients.Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Echinocandin Resistance in Candida.Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata Two echinocandin-resistant Candida glabrata FKS mutants from South Africa Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.Mechanisms of echinocandin antifungal drug resistance.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata Drug resistance mechanisms and their regulation in non-albicans Candida species.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.Changing epidemiology of candidaemia in Australia.Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.Echinocandins in antifungal pharmacotherapy.Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.Future Research Priorities in Fungal Resistance.Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling.Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor.

P2860

Q26750816-29F3634F-E7DA-4B6A-8118-A7668B3DB20E Q26996199-64749F90-CD56-408B-8F79-8F3E622C4580 Q28082538-75F39A50-A13F-41D6-8855-F543BFEA0FF9 Q28084998-5F270BDF-6A37-424F-8C12-B929D406B196 Q28544739-70BDA293-A049-46F9-AE06-64C0C79CA8E7 Q33715460-AB7698AB-4D65-4388-9CFA-3EABEC267743 Q34426755-67589B61-CA52-4605-BDBF-BC7F9300FB5D Q35487439-A8E0C15F-AF5C-4A54-A5F4-2FA6E6E0BF97 Q35635472-53BF7033-CCA5-4DA9-A9B1-8BFCC1C81BFB Q35997443-757C4CAE-199F-46DE-B283-EA80B85B630E Q35997516-7CF45B0F-5C90-465E-817E-CC9B3EB56F9D Q36158263-262E035E-92E0-40AF-8010-EF9FEC3D1BCE Q36276186-180B4486-62D8-45AE-A497-F8408FCADBE0 Q36290663-F346663F-9BA3-47D3-A433-C7727EEF795B Q36290758-E05FBA97-2AC9-4838-A3C8-7E5775393BED Q36385474-964B043C-6F21-46DA-887F-28B1AC3A5C8D Q36551326-7594C2C5-82FD-46CF-9618-646E410DDCD7 Q36740049-A088C74F-00AF-45C8-AE8E-4CFC639078CA Q37528498-FC503286-E2BF-4894-9B50-05F1526793C7 Q38550402-CD0E4C6A-E9C3-4B52-BEF3-1C44E3B37E40 Q38586680-F66CCD9F-9586-400E-841F-4F1559EA9D74 Q38589279-E888C319-B8EB-44B9-A71F-E0BEDC655A6D Q38613320-894112C9-9C92-4C13-BA42-3AA115948116 Q38708362-F3253D7B-1FD4-4AEE-A68B-F40BC6ECD145 Q38711698-11FA9173-48F9-4DAC-8FA9-695C680D97A2 Q38810300-78A8F019-0D15-48AC-B709-18F8E684E004 Q38863487-04F914EB-829A-4E94-95A1-3002737317CB Q38916677-201F9F6B-5DDB-4646-9B25-1B6221046AF2 Q39338332-7CEDCE8D-7474-43D2-97D9-8593AB06FDFC Q39458862-46EC406B-8A53-41EB-91CA-CDAD4FFE62AB Q39464983-A848B70A-A9B2-4740-8113-FA32FD43786D Q40040802-A6B05971-320E-4BF5-9AB8-D97741702B49 Q40045673-5FD26597-32E5-40C4-96E5-46495910CC52 Q40045680-C9E93969-B4AF-44DF-BABD-79A4500A3FC2 Q40080954-AEFEC318-B0E9-4069-9E00-E789B3E73190 Q40169961-551C525F-03A4-4796-8D96-3096ABE4AB1F Q40202924-9F197820-A155-4DB7-9F85-4C2D0F5B3786 Q40323063-F47D35B9-CCD2-424F-9EFC-1C963EC46B5B Q40448192-2BC005BC-27DB-44C7-88C1-F83E8E94A18D Q40602821-14552F22-2C50-4B25-822E-B39D5F55A19F

P2860

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.

http://www.wikidata.org/entity/Q34058099

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@ast

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@en

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@nl

type

label

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@ast

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@en

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@nl

prefLabel

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@ast

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@en

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@nl

P1433

Q34058099-5C2A1B0F-B245-476B-9F8C-FF473045221F

P1476

Q34058099-A88BE81D-E1D1-4D8A-8F35-C5AF22831FD0

P2093

Q34058099-07849B6E-4D01-44CD-9DD3-72D40219E570

Q34058099-0F50B299-DFA8-4948-80D3-F72F45C55255

Q34058099-42939FE7-4BE1-41FF-ABFB-04965E0B55B0

Q34058099-5AB790AF-A481-48AC-B0C5-368C6C960838

Q34058099-608084FC-A09C-47B7-BD66-00B7D3A7E8D0

Q34058099-794CCEDB-6DAE-4E3F-ACBD-845D148A2587

Q34058099-AFE6B9C6-A161-4BBE-9C57-FFD0246031FD

Q34058099-BFB2D3F1-F269-4366-A144-0DFA52B84E74

Q34058099-D28C39D3-1838-4653-903F-040D9905C30A

Q34058099-D3914947-824B-4FBB-A409-0DFA594C7437

P2860

Q34058099-02857AE4-A1A5-43A7-860E-EB7E3969A259

Q34058099-02EECFE9-EFFA-4172-B8C4-356A0745EDC1

Q34058099-07B6A018-5A91-49E8-8253-09A3DAB5238B

Q34058099-0964850E-AAA9-4FF0-BA64-5ACAC5D6D9EA

Q34058099-0EF3EF01-2158-4CD1-B9A7-C00F738E3CC6

Q34058099-11C41B15-C484-4B95-BB3B-167014AC5715

Q34058099-1332DE17-A081-45B4-A747-FC60A926D253

Q34058099-21518ACD-0CD1-441A-BA3B-5FB65113A652

Q34058099-26021327-F4BD-49F4-B578-7E8591B74234

Q34058099-29C42FE5-F5D8-4617-889C-BDBEC1AB1776

P304

Q34058099-C7DD61E3-EE2F-4192-AA31-A70B3DCEBBFF

P31

Q34058099-0778ADF7-35AE-456A-A625-46ACE3644B64

P356

Q34058099-B9FB6978-BD25-43D3-B860-66BB42B8962B

P407

Q34058099-58512CF1-E145-4A5B-B0F7-0C64B7F6AC29

P433

Q34058099-4F102065-797F-4DA8-82EA-82B66655386C

P478

Q34058099-01EE0DEC-F97D-403C-8CCE-D0E1DD22CD15

P50

Q34058099-3367715F-F0BF-45F8-93E2-5076EAF2F1F0

Q34058099-8132BC7A-D21C-4CBB-B0A4-FC41E50D5E02

P577

Q34058099-3C9EB5A9-6D74-43CE-A9BF-23629030992E

P698

Q34058099-071DFA51-C8BF-4AA4-9976-7560F51BAEB9

P921

Q34058099-1D21EBE0-E9A8-4962-BC4C-F75DA0A08F8D

Q34058099-788536EC-904B-4F1B-A4EF-07A47447B07B

P932

Q34058099-7937EAD0-72E5-4962-9CD4-DA3FBD24E288

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Role of FKS Mutations in Candi ...... nce, and multidrug resistance.

@en

P2093

Angela A Cleveland

http://www.w3.org/2001/XMLSchema#string

Benjamin J Park

http://www.w3.org/2001/XMLSchema#string

Carol B Bolden

http://www.w3.org/2001/XMLSchema#string

Cau D Pham

http://www.w3.org/2001/XMLSchema#string

Lee H Harrison

http://www.w3.org/2001/XMLSchema#string

Monica M Farley

http://www.w3.org/2001/XMLSchema#string

Naureen Iqbal

http://www.w3.org/2001/XMLSchema#string

Randall J Kuykendall

http://www.w3.org/2001/XMLSchema#string

Tom M Chiller

http://www.w3.org/2001/XMLSchema#string

Zintars G Beldavs

http://www.w3.org/2001/XMLSchema#string

P2860

Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.

Novel FKS mutations associated with echinocandin resistance in Candida species.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.

Breakthrough invasive candidiasis in patients on micafungin.

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.

P304

4690-4696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03255-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Shawn R Lockhart

William Schaffner

P577

2014-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24890592

http://www.w3.org/2001/XMLSchema#string

P921

Candida glabrata

multiple drug resistance

P932

4136002

http://www.w3.org/2001/XMLSchema#string